Skip to main content

Akoya to Participate at Three Upcoming Investor Conferences

MARLBOROUGH, Mass., July 26, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in three upcoming investor conferences.

  • Canaccord 43rd Annual Growth Conference
    Fireside Chat on Wednesday, August 9th at 9:00 AM ET
  • UBS MedTech, Tools & Genomics Summit
    Fireside Chat on Thursday, August 17th at 3:00 PM PT
  • Morgan Stanley 21st Annual Global Healthcare Conference
    Fireside Chat on Wednesday, September 13th at 10:10 AM ET

A live and archived webcast of the events will be available on the “Investors” section of the Akoya website at

About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit

Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.

Media Contact:
Christine Quern
(617) 650-8497


Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.